Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept phase II trial of intravitreal etamsylate for visual acuity in age-related macular degeneration
2014-005259-20Phase 2Completed
- Sponsor
- Investigacion Independiente
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of etamsylate in age-related macular degeneration (AMD) (2 arms), sponsored by Investigacion Independiente. Primary endpoint: Change in visual acuity at 4 weeks. Started Jan 2015; status: completed.
02
Drugs
etamsylate
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2014-005259-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005259-20.